Hikma Pharma Director Takes Role at Serco Group
Company Announcements

Hikma Pharma Director Takes Role at Serco Group

Hikma Pharmaceuticals (GB:HIK) has released an update.

Hikma Pharmaceuticals has announced that their Senior Independent Non-Executive Director, Victoria Hull, will join Serco Group PLC as a Non-Executive Director starting September 1, 2024. This move complies with the necessary regulatory disclosure for listed companies.

For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Reappoints PwC as Auditor
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Projects Strong Growth for 2024
TipRanks UK Auto-Generated NewsdeskHikma Pharmaceuticals Faces Shareholder Opposition on Buyback Waiver
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App